Skip to main content
OpenTrials

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,647 public trials 305 recruiting studies
Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group

NCT00000815

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +18 more
Locations
  • UAB, Dept. of Ped., Div. of Infectious Diseases Birmingham, Alabama, United States
  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
  • UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States
View all 46 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women.

NCT00000855

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Univ of Alabama at Birmingham - Pediatric Birmingham, Alabama, United States
  • Phoenix Childrens Hosp Phoenix, Arizona, United States
  • UCSD Med Ctr / Pediatrics / Clinical Sciences La Jolla, California, United States
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
View all 36 locations
View Trial Details
Completed

A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection

NCT00000750

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • Univ of Alabama at Birmingham Schl of Med / Pediatrics Birmingham, Alabama, United States
  • Kaiser Permanente / UCLA Med Ctr Downey, California, United States
  • UCLA Med Ctr / Pediatric Los Angeles, California, United States
  • Harbor - UCLA Med Ctr / UCLA School of Medicine Los Angeles, California, United States
View all 42 locations
View Trial Details
Completed

A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy

NCT00000820

Conditions
AIDS-Related Complex, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States
  • SUNY - Buffalo, Erie County Medical Ctr. Buffalo, New York, United States
View Trial Details
Completed

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children

NCT00000865

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Usc La Nichd Crs Los Angeles, California, United States
  • UCSD Maternal, Child, and Adolescent HIV CRS San Diego, California, United States
  • Tulane/LSU Maternal/Child CRS New Orleans, Louisiana, United States
  • Bronx-Lebanon Hosp. IMPAACT CRS The Bronx, New York, United States
View Trial Details
Completed

A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV

NCT00000791

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
View all 22 locations
View Trial Details
Completed

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum.

NCT00000866

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +14 more
Locations
  • JHU AVEG Baltimore, Maryland, United States
  • St. Louis Univ. School of Medicine AVEG St Louis, Missouri, United States
  • Vanderbilt Univ. Hosp. AVEG Nashville, Tennessee, United States
  • UW - Seattle AVEG Seattle, Washington, United States
View Trial Details
Completed

A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease

NCT00000814

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • Univ of Alabama at Birmingham Schl of Med / Pediatrics Birmingham, Alabama, United States
  • UCSD Med Ctr / Pediatrics / Clinical Sciences La Jolla, California, United States
  • Long Beach Memorial (Pediatric) Long Beach, California, United States
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
View all 68 locations
View Trial Details

Related conditions